DRUG SAFETY OPERATIONS IN AI ENVIRONMENT - Qtech-Sol USA offers Clinical Research / Trials, Pharmacovigilance, Drug Safety, Clinical Data Management, Clinical SAS Programming and Healthcare BA Training Programs
Category:
Drug Safety
 
Duration:
10 Weeks / 210 Hours
 

Drug Safety Operations in AI Environment

Introduction – Drug Safety Operations in AI Environment

Qtech-Sol presents a specialized training program designed for individuals seeking to pursue careers in pharmacovigilance and post-market drug safety within AI-supported environments. The DSAI program equips learners with critical knowledge of drug safety operations, regulatory compliance, and real-world safety reporting, while incorporating the use of AI technologies to enhance efficiency, accuracy, and decision-making.

This hybrid program bridges traditional pharmacovigilance tasks with AI innovations in adverse event processing, MedDRA coding, signal detection, PSUR, CIOMS line listings, and real-world evidence monitoring.

Course Name :  Drug Safety Operations in AI Environment (DSAI)
Course Code :  DSAI
Experience Level :  Entry to Mid-Level
Qualification :  Associate / Bachelors
Student Category :  Science Graduates / Career Changers
Course Material : This course delivers:
  1. 22 Core Drug Safety Lessons (Fundamentals of Pharmacovigilance) (Traditional Clinical Knowledge)
  2. 15 AI-Integrated Safety Operations Lessons (Hands-on LMS Exercises)
Each lesson includes:
  1. Narrated Presentations
  2. Reading Materials
  3. Practical Quizzes & Assessments
  4. AI-Augmented Role-Based Tasks
  5. Case Study Exercises and Safety Scenarios
Delivery Type

SIP – Self-Paced Online with Support

Course Duration

DSAI-SIP Delivery – 10 Weeks / 210 Hours (Self-Paced)

Educational Requirements:

Preferred Qualifications: To excel in roles within Drug Safety, candidates should hold an associate degree for entry-level data entry positions, while a bachelor’s or master’s degree in various science-related fields is highly recommended for more advanced roles. Eligible majors for enrollment span a diverse spectrum of disciplines, including Medicine, Nursing, Pharmacy, Public Health, Chemistry, Pharmacology, Pharmaceutical Chemistry for Drug Safety Associate roles, and Medical Reviewer or Drug Safety Physician positions.

Building Relevant Experience:

Drug Safety Associates (DSAs), Coordinators, and Specialists are essential to maintaining public health and regulatory compliance by overseeing drug safety activities throughout the lifecycle of pharmaceutical products—from clinical trials to post-marketing surveillance. The DSAI program is strategically designed to prepare learners for these roles by offering hands-on training in core pharmacovigilance functions, enhanced through artificial intelligence tools that are increasingly used in modern safety operations.

Through this program, students build practical, job-ready skills in the following areas:

Medical Record Review and Case Intake: Learn to evaluate patient histories and medical documents to identify reportable safety events and construct initial case entries.

Adverse Event Identification, Processing, and Follow-up: Gain expertise in identifying serious and non-serious adverse events (AEs and SAEs), processing them using standardized workflows, and performing required follow-ups with clinical sites and healthcare providers.

MedDRA Coding and Causality Assessments: Master the use of MedDRA (Medical Dictionary for Regulatory Activities) for accurate event classification and apply causality algorithms to determine drug-event relationships.

CIOMS, PSUR, and Signal Detection Techniques: Generate CIOMS reports, periodic safety update reports (PSURs), and utilize AI-enabled signal detection tools to recognize emerging drug safety concerns across patient populations.

SAE Reconciliation and Case Narrative Development: Learn to reconcile discrepancies between clinical trial databases and safety systems and draft comprehensive case narratives for regulatory submission.

AI-Supported Data Triage and Quality Reviews: Utilize AI for prioritizing incoming cases, flagging high-risk signals, and performing automated quality checks to improve efficiency and compliance.

Real-World Evidence (RWE) and Post-Market Surveillance:Explore post-marketing drug safety strategies, including monitoring data from electronic health records (EHRs), patient registries, and spontaneous reporting systems to ensure ongoing safety after product launch.

Throughout the program, students engage with real-world case scenarios, guided simulations, and standardized reporting templates that mirror current industry practices. By integrating AI-based automation tools with human judgment, learners develop a hybrid skill set that is in high demand across global pharmacovigilance teams

Job Roles After Completion of the DSAI Program:

Graduates of the Drug Safety Operations in AI Environment program are well-positioned to apply for a range of entry- to mid-level roles across pharmaceutical companies, clinical research organizations (CROs), biotech firms, and regulatory service providers. Common job titles include

   Entry-Level and Associate Roles

  1. Drug Safety Associate (DSA)
  2. Pharmacovigilance Associate (PVA)
  3. Safety Data Management Coordinator
  4. Drug Safety Coordinator
  5. Medical Data Reviewer
  6. Case Processing Specialist

    Mid-Level Roles (with experience or advancement)

  1. Signal Detection Analyst
  2. Risk Management Specialist
  3. Aggregate Report Specialist (CIOMS/PSUR)
  4. SAE Reconciliation Specialist
  5. Safety Surveillance Analyst
  6. AI-Powered PV Workflow Analyst

    Specialized Roles in Tech-Enabled PV

  1. MedDRA Coder / Medical Coding Specialist
  2. Pharmacovigilance Systems Analyst
  3. PV Automation Specialist
  4. Real-World Evidence (RWE) Analyst
  5. Post-Market Surveillance Coordinator

This program not only prepares students for immediate employment but also builds a strong foundation for career advancement in roles that require the integration of pharmacovigilance, data analytics, and emerging AI technologies.

Key Learning Outcomes and Student Benefits

   Learning Outcomes:

  1. Understand regulatory frameworks and reporting timelines (e.g., FDA, EudraVigilance).
  2. Perform medical data extraction, coding, and triage.
  3. Apply AI in detecting adverse event patterns and signal escalation.
  4. Use software for CIOMS, PSUR, and case management workflows.
  5. Interpret real-world data for post-market surveillance using AI tools.

    Benefits:

  1. 37+ practice hours of AI-integrated LMS training.
  2. Access to Drug Safety software simulations and tools.
  3. Resume Marketing Services (RMS) for job support.
  4. SME support, one-on-one guidance, and mock interviews.
  5. Internship and freelance job opportunities after course completion.
Support After Training

Upon completing the DSAI program, students gain exclusive access to Qtech-Sol’s Resume Marketing Services (RMS)—a comprehensive support system designed to accelerate job placement in AI-integrated clinical research roles.

   Our post-training assistance includes:

  1. Resume and LinkedIn Profile Optimization: Tailored to highlight both traditional DSA expertise and AI-driven capabilities.
  2. Narrative Development: Assistance in crafting compelling interview stories and responses aligned with real-world clinical-AI scenarios.
  3. Mock Interviews: Practice sessions focused on DSA responsibilities, regulatory compliance, and AI-enabled tools.
  4. Job Search Strategy & Market Insights: Personalized guidance on targeting the right roles, navigating job portals, and understanding hiring trends.
  5. Direct RMS Promotion: We actively market your resume to our employer network, helping bridge the gap between training and employment.

This end-to-end support ensures you are not only trained but truly career-ready, equipped to confidently pursue roles in modern clinical research environments powered by AI.

DSAI Curriculum Overview

Core Drug Safety Lessons:
1. Introduction to Clinical Research

2. Drug Development Process

3. Introduction to Drug Safety / Pharmacovigilance

4. Role of DSA / PVA in Clinical Trials

5. Introduction to Adverse Events

6. ICH-GCP Guidelines

7. Drug Safety Regulations and Compliance

8. Clinical Trial Protocol Overview

9. Characteristics of a Case

10. Sources of Individual Case Reports

11. Drug Safety Data Extraction and Pre-Processing

12. SOP Development

13. Communication with Cross-Functional Teams

14. Understanding 21 CFR Part 11 and HIPAA

15. Basics of Coding in Drug Safety

16. Case Follow-up and Handling

17. Clinical Trial Safety Surveillance

18. Phase IV Trials and Pharmacovigilance

19. Case Narratives

20. SAE Reconciliation

21. Drug Safety Databases and Software

22. Special Scenarios in Pharmacovigilance

AI-Integrated LMS Exercises:
• Lesson 1: MedDRA Coding

• Lesson 2: MedDRA Core Scenarios and Exercises

• Lesson 3: AE Causality Assessment Project

• Lesson 4: Risk Management and Pharmacovigilance

• Lesson 5: Introduction to REMS

• Lesson 6: Phase IV Reporting

• Lesson 7: Medical Record Extraction

• Lesson 8: Adverse Event Processing

• Lesson 9: CIOMS Line Listing

• Lesson 10: SOP Quality Control Revisions

• Lesson 11: SAE Reconciliation

• Lesson 12: PSUR Creation

• Lesson 13: Triage Simulation

• Lesson 14: Signal Detection using AI

• Lesson 15: Real-World Evidence (RWE) & Post-Market Surveillance

Getting in Touch:

For more information, please call us at +1 732.770.4100 / +1 732.207.4564 (WhatsApp) or email qpdc@qtech-solutions.com. Our course specialists will reach out to you promptly to assist you in taking the next steps toward your career goals.